APP and Alzheimer disease: In contrast to the receptor, the levels of IGF2 mRNA/peptide are reduced in AD brains (Pascual-Lucas et al., 2014; Rivera et al., 2005) and APP transgenic mice (Pascual-Lucas et al., 2014).